Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Medical imaging trends to watch in 2025
The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025.
Ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective
Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency.
Lantheus to acquire radiopharma firm Evergreen Theragnostics for up to $1B
Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors.
New data highlight ‘urgent need’ to expand access to lung cancer screenings
Experts estimate there are about 1.4M veterans eligible for LDCT screening, a rate three times higher than the general U.S. population.
Imaging agent developer Telix finalizes $250M purchase of RLS radiopharma network
RLS operates America’s only Joint Commission-accredited radiopharmacy network, with 31 locations covering over 85% of the U.S. population.

Medical imaging trends to watch in 2025

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025.

Jessica H. Porembka, MD, FSBI, associate professor, breast imaging division University of Texas Southwestern Medical Center, Dallas, and vice chair of strategy and quality, and quality assurance medical director, Parkland Radiology in Dallas, explains how an ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective.

Ultrasound-first strategy for noncalcified lesions in DBT proves cost-effective

Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency.

Lantheus to acquire radiopharma firm Evergreen Theragnostics for up to $1B

Founded in 2019, Evergreen develops and manufactures imaging agents aimed at diagnosing and treating cancer, including Octevy for neuroendocrine tumors.

New data highlight ‘urgent need’ to expand access to lung cancer screenings

Experts estimate there are about 1.4M veterans eligible for LDCT screening, a rate three times higher than the general U.S. population.

Imaging agent developer Telix finalizes $250M purchase of RLS radiopharma network

RLS operates America’s only Joint Commission-accredited radiopharmacy network, with 31 locations covering over 85% of the U.S. population.

Siemens Healthineers Mammomat B.brilliant

Siemens Healthineers touts 1st US installation of next-generation mammography system

Grace Breast Imaging & Medical Spa of Iowa—with locations in the Des Moines metro area communities of Clive and Urbandale—is rolling out the new 3D technology

AI needle-path generation slashes insertions times for CT-guided biopsies

The technology offers measurable benefits without sacrificing insertion accuracy, according to new research.

America’s cancer burden is shifting from men to women

Incidence rates among women 50 to 64 have now surpassed those of men, while cancer rates for females under 50 are 82% higher than their male counterparts, the ACS reports.

Around the web

Health Imaging

Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.